$CHRS
Coherus BioSciences Inc

2021 Q1 Form 10-Q Financial Statement

#000155837021006257 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $83.03M $116.2M
YoY Change -28.53% 213.17%
Cost Of Revenue $7.511M $6.855M
YoY Change 9.57% 208.09%
Gross Profit $75.52M $109.3M
YoY Change -30.92% 213.49%
Gross Profit Margin 90.95% 94.1%
Selling, General & Admin $39.39M $35.35M
YoY Change 11.43% 8.16%
% of Gross Profit 52.16% 32.33%
Research & Development $203.5M $33.11M
YoY Change 514.65% 76.2%
% of Gross Profit 269.44% 30.28%
Depreciation & Amortization $800.0K $600.0K
YoY Change 33.33% -14.29%
% of Gross Profit 1.06% 0.55%
Operating Expenses $242.9M $75.31M
YoY Change 222.5% 40.25%
Operating Profit -$167.4M $40.87M
YoY Change -509.51% -346.21%
Interest Expense $5.648M $4.431M
YoY Change 27.47% 5.1%
% of Operating Profit 10.84%
Other Income/Expense, Net $61.00K $68.00K
YoY Change -10.29% -91.62%
Pretax Income -$172.9M $36.51M
YoY Change -573.76% -282.49%
Income Tax $0.00 $900.0K
% Of Pretax Income 2.47%
Net Earnings -$172.9M $35.57M
YoY Change -586.19% -277.82%
Net Earnings / Revenue -208.28% 30.62%
Basic Earnings Per Share -$2.37 $0.50
Diluted Earnings Per Share -$2.37 $0.48
COMMON SHARES
Basic Shares Outstanding 72.83M 70.66M
Diluted Shares Outstanding 72.83M 74.42M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $399.5M $193.3M
YoY Change 106.67% 100.52%
Cash & Equivalents $259.5M $193.3M
Short-Term Investments $140.0M
Other Short-Term Assets $25.70M $18.00M
YoY Change 42.78% 28.57%
Inventory $51.61M $16.44M
Prepaid Expenses
Receivables $140.4M $167.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $617.3M $395.2M
YoY Change 56.2% 148.23%
LONG-TERM ASSETS
Property, Plant & Equipment $19.10M $6.832M
YoY Change 179.57% -47.04%
Goodwill $943.0K $943.0K
YoY Change 0.0% 0.0%
Intangibles $2.620M $2.620M
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets $10.70M $362.0K
YoY Change 2855.8% 2485.71%
Total Long-Term Assets $76.04M $71.36M
YoY Change 6.57% 165.12%
TOTAL ASSETS
Total Short-Term Assets $617.3M $395.2M
Total Long-Term Assets $76.04M $71.36M
Total Assets $693.3M $466.5M
YoY Change 48.61% 150.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.48M $20.49M
YoY Change -24.42% 83.34%
Accrued Expenses $44.84M $19.52M
YoY Change 129.71% 120.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $107.6M $100.0K
YoY Change 107500.0%
Total Short-Term Liabilities $257.6M $119.0M
YoY Change 116.45% 187.47%
LONG-TERM LIABILITIES
Long-Term Debt $298.9M $179.2M
YoY Change 66.8% 1.47%
Other Long-Term Liabilities $750.0K $11.10M
YoY Change -93.24%
Total Long-Term Liabilities $750.0K $190.3M
YoY Change -99.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $257.6M $119.0M
Total Long-Term Liabilities $750.0K $190.3M
Total Liabilities $565.6M $309.3M
YoY Change 82.9% 37.68%
SHAREHOLDERS EQUITY
Retained Earnings -$935.7M -$859.4M
YoY Change 8.88% -14.47%
Common Stock $7.000K $1.017B
YoY Change -100.0% 5.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $127.7M $157.3M
YoY Change
Total Liabilities & Shareholders Equity $693.3M $466.5M
YoY Change 48.61% 150.67%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$172.9M $35.57M
YoY Change -586.19% -277.82%
Depreciation, Depletion And Amortization $800.0K $600.0K
YoY Change 33.33% -14.29%
Cash From Operating Activities $1.367M $13.48M
YoY Change -89.86% -123.65%
INVESTING ACTIVITIES
Capital Expenditures $145.0K $1.783M
YoY Change -91.87% 432.24%
Acquisitions
YoY Change
Other Investing Activities -$285.3M $200.0K
YoY Change -142750.0% -101.34%
Cash From Investing Activities -$285.5M -$1.616M
YoY Change 17565.53% -89.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.439M 3.923M
YoY Change -37.83% -95.19%
NET CHANGE
Cash From Operating Activities 1.367M 13.48M
Cash From Investing Activities -285.5M -1.616M
Cash From Financing Activities 2.439M 3.923M
Net Change In Cash -281.7M 15.78M
YoY Change -1884.52% 72.33%
FREE CASH FLOW
Cash From Operating Activities $1.367M $13.48M
Capital Expenditures $145.0K $1.783M
Free Cash Flow $1.222M $11.69M
YoY Change -89.55% -120.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2021Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2021Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2021Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Redwood City
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94065
CY2021Q1 dei City Area Code
CityAreaCode
650
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
649-3530
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2021Q1 dei Trading Symbol
TradingSymbol
CHRS
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:PropertyPlantAndEquipmentNet
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:PropertyPlantAndEquipmentNet
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001512762
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73122908
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72513348
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-36721
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Coherus BioSciences, Inc.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3615821
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
333 Twin Dolphin Drive
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75752478
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
259489000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
541158000
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
140014000
CY2021Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
140410000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
157046000
CY2021Q1 us-gaap Inventory Net
InventoryNet
51613000
CY2020Q4 us-gaap Inventory Net
InventoryNet
44233000
CY2021Q1 chrs Prepaid Manufacturing Expense Current
PrepaidManufacturingExpenseCurrent
15385000
CY2020Q4 chrs Prepaid Manufacturing Expense Current
PrepaidManufacturingExpenseCurrent
19429000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10350000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5613000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
617261000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
767479000
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9670000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
10108000
CY2021Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
52065000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
47956000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2620000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2620000
CY2021Q1 us-gaap Goodwill
Goodwill
943000
CY2020Q4 us-gaap Goodwill
Goodwill
943000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10744000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12543000
CY2021Q1 us-gaap Assets
Assets
693303000
CY2020Q4 us-gaap Assets
Assets
841649000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15482000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15201000
CY2021Q1 chrs Accrued Rebates Fees And Reserve Current
AccruedRebatesFeesAndReserveCurrent
78202000
CY2020Q4 chrs Accrued Rebates Fees And Reserve Current
AccruedRebatesFeesAndReserveCurrent
81529000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12090000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22244000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44840000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26679000
CY2021Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
80240000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
257601000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
145653000
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
79885000
CY2021Q1 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
223341000
CY2020Q4 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
223029000
CY2021Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
74696000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
74481000
CY2021Q1 chrs Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
9244000
CY2020Q4 chrs Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
9948000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
750000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1051000
CY2021Q1 us-gaap Liabilities
Liabilities
565632000
CY2020Q4 us-gaap Liabilities
Liabilities
560675000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-172947000
CY2020Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
620000
CY2021Q1 us-gaap Interest Expense
InterestExpense
5648000
CY2020Q1 us-gaap Interest Expense
InterestExpense
4431000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
61000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
68000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.37
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73122908
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72513348
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
7000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1063672000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1043991000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-307000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-270000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-935701000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-762754000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
127671000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
280974000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
693303000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
841649000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
83034000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
116180000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7511000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6855000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
203492000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33107000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39391000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35350000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
250394000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
75312000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-167360000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
40868000
CY2021Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
631000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36505000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
933000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-172947000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
35572000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.37
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1001000
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
627000
CY2021Q1 chrs Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
526000
CY2020Q1 chrs Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
510000
CY2021Q1 chrs Upfront License Fee Payments Related To License And Collaboration Arrangements
UpfrontLicenseFeePaymentsRelatedToLicenseAndCollaborationArrangements
145000000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
203000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-4959000
CY2021Q1 chrs Increase Decrease In Accrued Rebates Fees And Reserve
IncreaseDecreaseInAccruedRebatesFeesAndReserve
-3327000
CY2020Q1 chrs Increase Decrease In Accrued Rebates Fees And Reserve
IncreaseDecreaseInAccruedRebatesFeesAndReserve
15037000
CY2021Q1 chrs Increase Decrease In Accrued Compensation
IncreaseDecreaseInAccruedCompensation
-10154000
CY2020Q1 chrs Increase Decrease In Accrued Compensation
IncreaseDecreaseInAccruedCompensation
-5632000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72832953
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70662185
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72832953
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74416554
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-172947000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
35572000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-37000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
608000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-172984000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
36180000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
280974000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4429000
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1730000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16982000
CY2021Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-37000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-172947000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
127671000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
105214000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4438000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2378000
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
880000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9945000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
35572000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
157275000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-172947000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
35572000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
849000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
607000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
16884000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9555000
CY2021Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-3210000
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-279000
CY2021Q1 chrs Other Noncash Adjustments
OtherNoncashAdjustments
173000
CY2020Q1 chrs Other Noncash Adjustments
OtherNoncashAdjustments
636000
CY2021Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-16663000
CY2020Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
25626000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11378000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9608000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2109000
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3100000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4621000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1788000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
16897000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1646000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1367000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13477000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
145000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1783000
CY2020Q1 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
167000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
140330000
CY2021Q1 chrs Upfront And Milestone Payments Related To License And Collaboration Arrangements
UpfrontAndMilestonePaymentsRelatedToLicenseAndCollaborationArrangements
145000000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-285475000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1616000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4329000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4803000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1730000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
880000
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-160000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2439000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3923000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-281669000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15784000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
541598000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177908000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259929000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193692000
CY2020Q1 chrs Unpaid Upfront License Fee To Innovent Included In Accounts Payable
UnpaidUpfrontLicenseFeeToInnoventIncludedInAccountsPayable
5000000
CY2020Q1 chrs Non Cash Bonus Payment Settled In Common Stock
NonCashBonusPaymentSettledInCommonStock
1498000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1388000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
212000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
257000
CY2021Q1 chrs Number Of Products
NumberOfProducts
4
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:24.5pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. These estimates form the basis for making judgments about the carrying values of assets and liabilities when these values are not readily apparent from other sources. Accounting estimates and judgements are inherently uncertain and the actual results could differ from these estimates.</p>
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10700000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9400000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12500000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10000000.0
CY2021Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-3200000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177908000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
259489000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193252000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
440000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
440000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
259929000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193692000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
541158000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177668000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
440000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
240000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
541598000
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3727000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5205000
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
61644000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
43952000
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
38307000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
43032000
CY2021Q1 us-gaap Inventory Gross
InventoryGross
103678000
CY2020Q4 us-gaap Inventory Gross
InventoryGross
92189000
CY2021Q1 us-gaap Inventory Net
InventoryNet
51613000
CY2020Q4 us-gaap Inventory Net
InventoryNet
44233000
CY2021Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
52065000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
47956000
CY2021Q1 chrs Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
103678000
CY2020Q4 chrs Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
92189000
CY2021Q1 chrs Prepaid Manufacturing Expense Current
PrepaidManufacturingExpenseCurrent
15400000
CY2020Q4 chrs Prepaid Manufacturing Expense Current
PrepaidManufacturingExpenseCurrent
19400000
CY2021Q1 chrs Cancellation Of Open Purchase Orders With Various Vendors
CancellationOfOpenPurchaseOrdersWithVariousVendors
8300000
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
26949000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
26158000
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
17279000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
16050000
CY2021Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9670000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
10108000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
800000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
600000
CY2021Q1 chrs Accrued Clinical And Manufacturing Liabilities Current
AccruedClinicalAndManufacturingLiabilitiesCurrent
30608000
CY2020Q4 chrs Accrued Clinical And Manufacturing Liabilities Current
AccruedClinicalAndManufacturingLiabilitiesCurrent
11365000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10944000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12182000
CY2021Q1 chrs Lease Liabilities Operating And Financing
LeaseLiabilitiesOperatingAndFinancing
3288000
CY2020Q4 chrs Lease Liabilities Operating And Financing
LeaseLiabilitiesOperatingAndFinancing
3132000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44840000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26679000
CY2020Q4 chrs Reserve For Discounts And Allowances Constitute Variable Consideration
ReserveForDiscountsAndAllowancesConstituteVariableConsideration
123398000
CY2021Q1 chrs Reserve For Sales Discounts And Allowances Constitute Variable Consideration
ReserveForSalesDiscountsAndAllowancesConstituteVariableConsideration
170033000
CY2021Q1 chrs Provision Related To Sales Made In Prior Period
ProvisionRelatedToSalesMadeInPriorPeriod
-5027000
CY2021Q1 chrs Payments And Customer Credits Issued From Reserve For Discounts And Allowances Constitute Variable Consideration
PaymentsAndCustomerCreditsIssuedFromReserveForDiscountsAndAllowancesConstituteVariableConsideration
176971000
CY2021Q1 chrs Reserve For Discounts And Allowances Constitute Variable Consideration
ReserveForDiscountsAndAllowancesConstituteVariableConsideration
111433000
CY2019Q4 chrs Reserve For Discounts And Allowances Constitute Variable Consideration
ReserveForDiscountsAndAllowancesConstituteVariableConsideration
87147000
CY2020Q1 chrs Reserve For Sales Discounts And Allowances Constitute Variable Consideration
ReserveForSalesDiscountsAndAllowancesConstituteVariableConsideration
161492000
CY2020Q1 chrs Provision Related To Sales Made In Prior Period
ProvisionRelatedToSalesMadeInPriorPeriod
1038000
CY2020Q1 chrs Payments And Customer Credits Issued From Reserve For Discounts And Allowances Constitute Variable Consideration
PaymentsAndCustomerCreditsIssuedFromReserveForDiscountsAndAllowancesConstituteVariableConsideration
150498000
CY2020Q1 chrs Reserve For Discounts And Allowances Constitute Variable Consideration
ReserveForDiscountsAndAllowancesConstituteVariableConsideration
99179000
CY2020Q2 chrs Equivalent To Conversion Price Per Common Share
EquivalentToConversionPricePerCommonShare
14.815
CY2021Q1 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
34204000
CY2021Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
15946000
CY2021Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
9753000
CY2021Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
600000
CY2021Q1 us-gaap Purchase Obligation
PurchaseObligation
60503000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9430000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9956000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1508000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1451000
CY2021Q1 chrs Operating And Finance Lease Right Of Use Assets
OperatingAndFinanceLeaseRightOfUseAssets
10938000
CY2020Q4 chrs Operating And Finance Lease Right Of Use Assets
OperatingAndFinanceLeaseRightOfUseAssets
11407000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2651000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2573000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8375000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9073000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
11026000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11646000
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
637000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
560000
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
869000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
875000
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
1506000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
1435000
CY2020Q1 us-gaap Lease Cost
LeaseCost
800000
CY2021Q1 us-gaap Lease Cost
LeaseCost
800000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
900000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
800000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2572000
CY2021Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
530000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3293000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
700000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3438000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
360000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2889000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
16000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
700000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12892000
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1606000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1866000
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
100000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
11026000
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
1506000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.081
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.081
CY2021Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2021Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.058
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.058
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-172947000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
35572000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72832953
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70662185
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.37
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-172947000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
35572000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72832953
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70662185
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3666137
CY2020Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
88232
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
72832953
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
74416554
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.37
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37997305
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13340897
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000

Files In Submission

Name View Source Status
0001558370-21-006257-index-headers.html Edgar Link pending
0001558370-21-006257-index.html Edgar Link pending
0001558370-21-006257.txt Edgar Link pending
0001558370-21-006257-xbrl.zip Edgar Link pending
chrs-20210331.xsd Edgar Link pending
chrs-20210331x10q.htm Edgar Link pending
chrs-20210331x10q_htm.xml Edgar Link completed
chrs-20210331xex10d1.htm Edgar Link pending
chrs-20210331xex10d1001.jpg Edgar Link pending
chrs-20210331xex10d1002.jpg Edgar Link pending
chrs-20210331xex10d2.htm Edgar Link pending
chrs-20210331xex31d1.htm Edgar Link pending
chrs-20210331xex31d2.htm Edgar Link pending
chrs-20210331xex32d1.htm Edgar Link pending
chrs-20210331_cal.xml Edgar Link unprocessable
chrs-20210331_def.xml Edgar Link unprocessable
chrs-20210331_lab.xml Edgar Link unprocessable
chrs-20210331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending